In addition, they revealed that knockdown of OGT in RCC cells could downregulate the epidermal growth factor receptor (EGFR) and PI3K/AKT pathways, thereby inhibiting the migration, invasion, and vascularization of RCC cells. Here, OGT is linked to renal cell carcinoma.